...
首页> 外文期刊>Emerging microbes & infections. >An update on the human and animal enteric pathogen Clostridium perfringens
【24h】

An update on the human and animal enteric pathogen Clostridium perfringens

机译:人和动物肠道病原菌产气荚膜梭菌的最新进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Clostridium perfringens , a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past century. Recent advances in genomic analysis and experimental systems make it timely to re-visit this clinically and veterinary important pathogen. This Review will summarise our understanding of the genomics and virulence-linked factors, including antimicrobial potentials and secreted toxins of this gut pathogen, and then its up-to-date clinical epidemiology and biological role in the pathogenesis of several important human and animal-associated intestinal diseases, including pre-term necrotising enterocolitis. Finally, we highlight some of the important unresolved questions in relation to C. perfringens -mediated infections, and implications for future research directions.
机译:产气荚膜梭菌(Clostridium perfringens)是一种快速生长的病原体,已知会分泌超过20种有毒毒素的武库,在过去的一个世纪中已与动物和人类的肠道疾病相关。基因组分析和实验系统的最新进展使得及时重新审视这种临床和兽医学重要病原体成为可能。这篇综述将总结我们对基因组学和毒力相关因素的理解,包括该肠道病原体的抗菌潜力和分泌的毒素,以及其在几种重要的人畜相关疾病的发病机理中的最新临床流行病学和生物学作用。肠道疾病包括早发型坏死性小肠结肠炎。最后,我们重点介绍与产气荚膜梭菌介导的感染有关的一些重要未解决问题,以及对未来研究方向的启示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号